ID   ENOB_HUMAN              Reviewed;         434 AA.
AC   P13929; B4DUI6; B4DUM6; D3DTL2; E7ENK8; Q96AE2;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2012, sequence version 5.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Beta-enolase;
DE            EC=4.2.1.11;
DE   AltName: Full=2-phospho-D-glycerate hydro-lyase;
DE   AltName: Full=Enolase 3;
DE   AltName: Full=Muscle-specific enolase;
DE            Short=MSE;
DE   AltName: Full=Skeletal muscle enolase;
GN   Name=ENO3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2587223; DOI=10.1093/nar/17.21.8862;
RA   Peshavaria M., Hinks L.J., Day I.N.M.;
RT   "Structure of human muscle (beta) enolase mRNA and protein deduced
RT   from a genomic clone.";
RL   Nucleic Acids Res. 17:8862-8862(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-85.
RX   PubMed=2336366; DOI=10.1093/nar/18.7.1893;
RA   Cali L., Feo S., Oliva D., Giallongo A.;
RT   "Nucleotide sequence of a cDNA encoding the human muscle-specific
RT   enolase (MSE).";
RL   Nucleic Acids Res. 18:1893-1893(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=1840492; DOI=10.1042/bj2750427;
RA   Peshavaria M., Day I.N.M.;
RT   "Molecular structure of the human muscle-specific enolase gene
RT   (ENO3).";
RL   Biochem. J. 275:427-433(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANTS SER-71 AND
RP   ALA-85.
RX   PubMed=8513787; DOI=10.1111/j.1432-1033.1993.tb17932.x;
RA   Giallongo A., Venturella S., Oliva D., Barbieri G., Rubino P., Feo S.;
RT   "Structural features of the human gene for muscle-specific enolase.
RT   Differential splicing in the 5'-untranslated sequence generates two
RT   forms of mRNA.";
RL   Eur. J. Biochem. 214:367-374(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANTS SER-71 AND ALA-85.
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   SER-71 AND ALA-85.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH PNKD.
RX   PubMed=15188056; DOI=10.1093/abbs/36.6.412;
RA   Li T.-B., Liu X.-H., Feng S., Hu Y., Yang W.-X., Han Y., Wang Y.-G.,
RA   Gong L.-M.;
RT   "Characterization of MR-1, a novel myofibrillogenesis regulator in
RT   human muscle.";
RL   Acta Biochim. Biophys. Sin. 36:412-418(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-176 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANTS GSD13 ASP-156 AND GLU-374.
RX   PubMed=11506403; DOI=10.1002/ana.1095;
RA   Comi G.P., Fortunato F., Lucchiari S., Bordoni A., Prelle A., Jann S.,
RA   Keller A., Ciscato P., Galbiati S., Chiveri L., Torrente Y.,
RA   Scarlato G., Bresolin N.;
RT   "Beta-enolase deficiency, a new metabolic myopathy of distal
RT   glycolysis.";
RL   Ann. Neurol. 50:202-207(2001).
CC   -!- FUNCTION: Appears to have a function in striated muscle
CC       development and regeneration.
CC   -!- CATALYTIC ACTIVITY: 2-phospho-D-glycerate = phosphoenolpyruvate +
CC       H(2)O.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Mg(2+) is required for catalysis and for stabilizing the
CC       dimer.;
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 4/5.
CC   -!- SUBUNIT: Mammalian enolase is composed of 3 isozyme subunits,
CC       alpha, beta and gamma, which can form homodimers or heterodimers
CC       which are cell-type and development-specific. Interacts with PNKD.
CC       {ECO:0000269|PubMed:15188056}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Localized to the Z line.
CC       Some colocalization with CKM at M-band (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P13929-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13929-2; Sequence=VSP_037753;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P13929-3; Sequence=VSP_037752;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: The alpha/alpha homodimer is expressed in
CC       embryo and in most adult tissues. The alpha/beta heterodimer and
CC       the beta/beta homodimer are found in striated muscle, and the
CC       alpha/gamma heterodimer and the gamma/gamma homodimer in neurons.
CC   -!- DEVELOPMENTAL STAGE: During ontogenesis, there is a transition
CC       from the alpha/alpha homodimer to the alpha/beta heterodimer in
CC       striated muscle cells, and to the alpha/gamma heterodimer in nerve
CC       cells.
CC   -!- DISEASE: Glycogen storage disease 13 (GSD13) [MIM:612932]: A
CC       metabolic disorder that results in exercise-induced myalgias,
CC       generalized muscle weakness and fatigability. It is characterized
CC       by increased serum creatine kinase and decreased enolase 3
CC       activity. Dramatically reduced protein levels with focal
CC       sarcoplasmic accumulation of glycogen-beta particles are detected
CC       on ultrastructural analysis. {ECO:0000269|PubMed:11506403}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the enolase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16504; CAA34513.1; -; mRNA.
DR   EMBL; X51957; CAA36216.1; -; mRNA.
DR   EMBL; X55976; CAA39446.1; -; Genomic_DNA.
DR   EMBL; X56832; CAA40163.1; -; Genomic_DNA.
DR   EMBL; AK300662; BAG62348.1; -; mRNA.
DR   EMBL; AK300709; BAG62388.1; -; mRNA.
DR   EMBL; AC004771; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC109333; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90375.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90379.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90380.1; -; Genomic_DNA.
DR   EMBL; BC017249; AAH17249.1; -; mRNA.
DR   CCDS; CCDS11062.1; -. [P13929-1]
DR   CCDS; CCDS54070.1; -. [P13929-3]
DR   PIR; S06756; S06756.
DR   RefSeq; NP_001180432.1; NM_001193503.1. [P13929-3]
DR   RefSeq; NP_001967.3; NM_001976.4. [P13929-1]
DR   RefSeq; NP_443739.3; NM_053013.3. [P13929-1]
DR   RefSeq; XP_011522031.1; XM_011523729.1. [P13929-1]
DR   RefSeq; XP_016879835.1; XM_017024346.1. [P13929-1]
DR   UniGene; Hs.224171; -.
DR   PDB; 2XSX; X-ray; 1.70 A; A/B=1-434.
DR   PDBsum; 2XSX; -.
DR   ProteinModelPortal; P13929; -.
DR   SMR; P13929; -.
DR   BioGrid; 108341; 43.
DR   IntAct; P13929; 20.
DR   STRING; 9606.ENSP00000324105; -.
DR   DrugBank; DB03465; 2-Phospho-D-Glyceric Acid.
DR   DrugBank; DB02726; 2-Phosphoglycolic Acid.
DR   DrugBank; DB01819; Phosphoenolpyruvate.
DR   DrugBank; DB03645; Phosphonoacetohydroxamic Acid.
DR   iPTMnet; P13929; -.
DR   PhosphoSitePlus; P13929; -.
DR   SwissPalm; P13929; -.
DR   BioMuta; ENO3; -.
DR   DMDM; 425906077; -.
DR   UCD-2DPAGE; P13929; -.
DR   EPD; P13929; -.
DR   MaxQB; P13929; -.
DR   PaxDb; P13929; -.
DR   PeptideAtlas; P13929; -.
DR   PRIDE; P13929; -.
DR   DNASU; 2027; -.
DR   Ensembl; ENST00000323997; ENSP00000324105; ENSG00000108515. [P13929-1]
DR   Ensembl; ENST00000518175; ENSP00000431087; ENSG00000108515. [P13929-1]
DR   Ensembl; ENST00000519584; ENSP00000430636; ENSG00000108515. [P13929-3]
DR   GeneID; 2027; -.
DR   KEGG; hsa:2027; -.
DR   UCSC; uc002gac.5; human. [P13929-1]
DR   CTD; 2027; -.
DR   DisGeNET; 2027; -.
DR   GeneCards; ENO3; -.
DR   H-InvDB; HIX0013457; -.
DR   HGNC; HGNC:3354; ENO3.
DR   HPA; HPA000793; -.
DR   HPA; HPA068284; -.
DR   MalaCards; ENO3; -.
DR   MIM; 131370; gene.
DR   MIM; 612932; phenotype.
DR   neXtProt; NX_P13929; -.
DR   OpenTargets; ENSG00000108515; -.
DR   Orphanet; 99849; Glycogen storage disease due to muscle beta-enolase deficiency.
DR   PharmGKB; PA27789; -.
DR   eggNOG; KOG2670; Eukaryota.
DR   eggNOG; COG0148; LUCA.
DR   GeneTree; ENSGT00840000129817; -.
DR   HOGENOM; HOG000072174; -.
DR   HOVERGEN; HBG000067; -.
DR   InParanoid; P13929; -.
DR   KO; K01689; -.
DR   OMA; ETEDTFM; -.
DR   OrthoDB; EOG091G07NH; -.
DR   PhylomeDB; P13929; -.
DR   TreeFam; TF300391; -.
DR   BioCyc; MetaCyc:ENSG00000108515-MONOMER; -.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P13929; -.
DR   SIGNOR; P13929; -.
DR   UniPathway; UPA00109; UER00187.
DR   ChiTaRS; ENO3; human.
DR   GeneWiki; ENO3; -.
DR   GenomeRNAi; 2027; -.
DR   PRO; PR:P13929; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108515; -.
DR   CleanEx; HS_ENO3; -.
DR   ExpressionAtlas; P13929; baseline and differential.
DR   Genevisible; P13929; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:CAFA.
DR   GO; GO:0000015; C:phosphopyruvate hydratase complex; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004634; F:phosphopyruvate hydratase activity; TAS:Reactome.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl.
DR   CDD; cd03313; enolase; 1.
DR   Gene3D; 3.20.20.120; -; 1.
DR   Gene3D; 3.30.390.10; -; 1.
DR   HAMAP; MF_00318; Enolase; 1.
DR   InterPro; IPR000941; Enolase.
DR   InterPro; IPR034390; Enolase-like_superfamily.
DR   InterPro; IPR020810; Enolase_C.
DR   InterPro; IPR029065; Enolase_C-like.
DR   InterPro; IPR020809; Enolase_CS.
DR   InterPro; IPR020811; Enolase_N.
DR   InterPro; IPR029017; Enolase_N-like.
DR   PANTHER; PTHR11902; PTHR11902; 1.
DR   Pfam; PF00113; Enolase_C; 1.
DR   Pfam; PF03952; Enolase_N; 1.
DR   PIRSF; PIRSF001400; Enolase; 1.
DR   PRINTS; PR00148; ENOLASE.
DR   SFLD; SFLDG00178; enolase; 1.
DR   SFLD; SFLDS00001; Enolase; 1.
DR   SMART; SM01192; Enolase_C; 1.
DR   SMART; SM01193; Enolase_N; 1.
DR   SUPFAM; SSF51604; SSF51604; 1.
DR   SUPFAM; SSF54826; SSF54826; 1.
DR   TIGRFAMs; TIGR01060; eno; 1.
DR   PROSITE; PS00164; ENOLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Disease mutation; Glycogen storage disease; Glycolysis;
KW   Lyase; Magnesium; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    434       Beta-enolase.
FT                                /FTId=PRO_0000134107.
FT   REGION      370    373       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    210    210       Proton donor. {ECO:0000250}.
FT   ACT_SITE    343    343       Proton acceptor. {ECO:0000250}.
FT   METAL       245    245       Magnesium. {ECO:0000250}.
FT   METAL       293    293       Magnesium. {ECO:0000250}.
FT   METAL       318    318       Magnesium. {ECO:0000250}.
FT   BINDING     158    158       Substrate. {ECO:0000250}.
FT   BINDING     167    167       Substrate. {ECO:0000250}.
FT   BINDING     293    293       Substrate. {ECO:0000250}.
FT   BINDING     318    318       Substrate. {ECO:0000250}.
FT   BINDING     394    394       Substrate. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      26     26       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P09104}.
FT   MOD_RES      44     44       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P09104}.
FT   MOD_RES      72     72       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P15429}.
FT   MOD_RES      83     83       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15429}.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15429}.
FT   MOD_RES     176    176       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     197    197       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17183}.
FT   MOD_RES     199    199       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17183}.
FT   MOD_RES     205    205       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P15429}.
FT   MOD_RES     229    229       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P15429}.
FT   MOD_RES     236    236       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P15429}.
FT   MOD_RES     263    263       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      61    104       GVLKAVENINNTLGPALLQKKLSVVDQEKVDKFMIELDGTE
FT                                NKS -> A (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037752.
FT   VAR_SEQ     150    177       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037753.
FT   VARIANT      71     71       N -> S (in dbSNP:rs238238).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8513787}.
FT                                /FTId=VAR_020618.
FT   VARIANT      85     85       V -> A (in dbSNP:rs238239).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2336366,
FT                                ECO:0000269|PubMed:8513787}.
FT                                /FTId=VAR_020619.
FT   VARIANT     156    156       G -> D (in GSD13; when associated with E-
FT                                374; dbSNP:rs121918403).
FT                                {ECO:0000269|PubMed:11506403}.
FT                                /FTId=VAR_020620.
FT   VARIANT     374    374       G -> E (in GSD13; when associated with D-
FT                                156; dbSNP:rs121918404).
FT                                {ECO:0000269|PubMed:11506403}.
FT                                /FTId=VAR_020621.
FT   STRAND        5     12       {ECO:0000244|PDB:2XSX}.
FT   STRAND       18     26       {ECO:0000244|PDB:2XSX}.
FT   STRAND       29     34       {ECO:0000244|PDB:2XSX}.
FT   STRAND       43     45       {ECO:0000244|PDB:2XSX}.
FT   HELIX        57     59       {ECO:0000244|PDB:2XSX}.
FT   HELIX        63     71       {ECO:0000244|PDB:2XSX}.
FT   HELIX        73     79       {ECO:0000244|PDB:2XSX}.
FT   HELIX        87     98       {ECO:0000244|PDB:2XSX}.
FT   TURN        104    106       {ECO:0000244|PDB:2XSX}.
FT   HELIX       108    125       {ECO:0000244|PDB:2XSX}.
FT   HELIX       130    138       {ECO:0000244|PDB:2XSX}.
FT   STRAND      150    154       {ECO:0000244|PDB:2XSX}.
FT   HELIX       156    158       {ECO:0000244|PDB:2XSX}.
FT   STRAND      159    162       {ECO:0000244|PDB:2XSX}.
FT   STRAND      167    171       {ECO:0000244|PDB:2XSX}.
FT   HELIX       178    200       {ECO:0000244|PDB:2XSX}.
FT   HELIX       220    234       {ECO:0000244|PDB:2XSX}.
FT   TURN        237    239       {ECO:0000244|PDB:2XSX}.
FT   STRAND      241    245       {ECO:0000244|PDB:2XSX}.
FT   HELIX       248    251       {ECO:0000244|PDB:2XSX}.
FT   TURN        259    262       {ECO:0000244|PDB:2XSX}.
FT   HELIX       267    269       {ECO:0000244|PDB:2XSX}.
FT   HELIX       273    286       {ECO:0000244|PDB:2XSX}.
FT   STRAND      289    293       {ECO:0000244|PDB:2XSX}.
FT   HELIX       301    309       {ECO:0000244|PDB:2XSX}.
FT   STRAND      313    318       {ECO:0000244|PDB:2XSX}.
FT   TURN        319    323       {ECO:0000244|PDB:2XSX}.
FT   HELIX       325    334       {ECO:0000244|PDB:2XSX}.
FT   STRAND      338    342       {ECO:0000244|PDB:2XSX}.
FT   HELIX       344    347       {ECO:0000244|PDB:2XSX}.
FT   HELIX       350    362       {ECO:0000244|PDB:2XSX}.
FT   STRAND      366    370       {ECO:0000244|PDB:2XSX}.
FT   HELIX       380    388       {ECO:0000244|PDB:2XSX}.
FT   STRAND      391    394       {ECO:0000244|PDB:2XSX}.
FT   HELIX       401    417       {ECO:0000244|PDB:2XSX}.
FT   HELIX       418    420       {ECO:0000244|PDB:2XSX}.
FT   HELIX       425    427       {ECO:0000244|PDB:2XSX}.
SQ   SEQUENCE   434 AA;  46987 MW;  4D9D8DCF32CF153F CRC64;
     MAMQKIFARE ILDSRGNPTV EVDLHTAKGR FRAAVPSGAS TGIYEALELR DGDKGRYLGK
     GVLKAVENIN NTLGPALLQK KLSVVDQEKV DKFMIELDGT ENKSKFGANA ILGVSLAVCK
     AGAAEKGVPL YRHIADLAGN PDLILPVPAF NVINGGSHAG NKLAMQEFMI LPVGASSFKE
     AMRIGAEVYH HLKGVIKAKY GKDATNVGDE GGFAPNILEN NEALELLKTA IQAAGYPDKV
     VIGMDVAASE FYRNGKYDLD FKSPDDPARH ITGEKLGELY KSFIKNYPVV SIEDPFDQDD
     WATWTSFLSG VNIQIVGDDL TVTNPKRIAQ AVEKKACNCL LLKVNQIGSV TESIQACKLA
     QSNGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL MRIEEALGDK
     AIFAGRKFRN PKAK
//
